Expertise in
15
conditions

Dr. Mohammad H. Fekrazad

Hematology Oncology | Hematology | Oncology
Kaiser Permanente
Antelope Valley Medical Offices
615 W Avenue L, 
Lancaster, CA 
Accepting New Patients
Offers Telehealth
Expertise in
15
conditions
Kaiser Permanente
Antelope Valley Medical Offices
615 W Avenue L, 
Lancaster, CA 

Overview

Mohammad Fekrazad is a Hematologist Oncology specialist and a Hematologist practicing medicine in Lancaster, California.

Dr. Fekrazad is highly rated in 15 conditions, according to our data. His clinical expertise encompasses Breast Cancer, Pleuropulmonary Blastoma, Squamous Cell Lung Carcinoma, and Small Cell Lung Cancer (SCLC).

He is actively involved in clinical research, co-authoring 1 peer reviewed article and participating in 7 clinical trials. Dr. Fekrazad is currently accepting new patients.

Specialties

Hematology Oncology
Hematology
Oncology

Licenses

Internal Medicine in NM

Hospital Affiliations

Kaiser Foundation Hospital - Panorama City
Antelope Valley Hospital

Languages Spoken

English

Gender

Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Cigna
  • EPO
  • HMO
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO

Locations

Antelope Valley Medical Offices
615 W Avenue L, Lancaster, CA 93534

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

5 Clinical Trials

Phase II Study of the Combination of Pembrolizumab, Letrozole, and Palbociclib in Postmenopausal Patients With Newly Diagnosed Metastatic Estrogen Receptor Positive Breast Cancer
Phase II Study of the Combination of Pembrolizumab, Letrozole, and Palbociclib in Postmenopausal Patients With Newly Diagnosed Metastatic Estrogen Receptor Positive Breast Cancer
Enrollment Status: Active_not_recruiting
Publish Date: February 24, 2026
Intervention Type: Drug, Other, Biological
Study Drugs: Letrozole, Palbociclib, Pembrolizumab
Study Phase: Phase 2
A Phase I Clinical Trial of Trametinib in Combination With TAS-102 in Patients With Chemotherapy-Resistant RAS-Mutated (PIK3CA/PTEN-Wild-Type) Metastatic Colorectal Cancer
A Phase I Clinical Trial of Trametinib in Combination With TAS-102 in Patients With Chemotherapy-Resistant RAS-Mutated (PIK3CA/PTEN-Wild-Type) Metastatic Colorectal Cancer
Enrollment Status: Completed
Publish Date: April 08, 2024
Intervention Type: Drug, Other
Study Drugs: Trametinib, Trifluridine, Tipiracil Hydrochloride
Study Phase: Phase 1
A Phase 2 Clinical Trial of the Combination of Pembrolizumab and Selective Androgen Receptor Modulator (SARM) GTX-024 in Patients With Metastatic Androgen Receptor (AR) Positive Triple Negative Breast Cancer (TNBC)
A Phase 2 Clinical Trial of the Combination of Pembrolizumab and Selective Androgen Receptor Modulator (SARM) GTX-024 in Patients With Metastatic Androgen Receptor (AR) Positive Triple Negative Breast Cancer (TNBC)
Enrollment Status: Completed
Publish Date: February 20, 2024
Intervention Type: Drug, Other, Biological
Study Drugs: Enobosarm, Pembrolizumab
Study Phase: Phase 2
A Phase IIA Trial Assessing the Tolerability of Ribociclib in Combination With an Aromatase Inhibitor in Patients Aged 70 and Older With Hormone Receptor Positive Metastatic Breast Cancer
A Phase IIA Trial Assessing the Tolerability of Ribociclib in Combination With an Aromatase Inhibitor in Patients Aged 70 and Older With Hormone Receptor Positive Metastatic Breast Cancer
Enrollment Status: Completed
Publish Date: February 20, 2024
Intervention Type: Drug, Other
Study Drugs: Aromatase Inhibitor, Ribociclib
Study Phase: Phase 2
Phase II Study of Neratinib in Patients 60 and Older With HER2 Positive Metastatic Breast Cancer
Phase II Study of Neratinib in Patients 60 and Older With HER2 Positive Metastatic Breast Cancer
Enrollment Status: Completed
Publish Date: June 18, 2023
Intervention Type: Other, Drug
Study Drug: Neratinib
Study Phase: Phase 2
View 4 Less Clinical Trials

1 Total Publications

Anaplastic large cell lymphoma associated with breast implants.
Anaplastic large cell lymphoma associated with breast implants.
Journal: World journal of plastic surgery
Published: January 01, 2012
Similar Doctors
Expertise in
11
conditions
Dr. Thomas D. Coates
Hematology | Oncology
Expertise in
11
conditions
Dr. Thomas D. Coates
Hematology | Oncology
Referral may be required

Office

4650 W Sunset Blvd # 54, 
Los Angeles, CA 
 (39.8 miles away)
323-361-4624
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Thomas Coates is a Hematologist and an Oncologist practicing medicine in Los Angeles, California. Dr. Coates is highly rated in 11 conditions, according to our data. His clinical expertise encompasses Hemoglobinopathy, Anemia, Congenital Hemolytic Anemia, Splenectomy, and Bone Marrow Transplant.

Expertise in
55
conditions
Dr. Stephen J. Forman
Hematology | Oncology
Expertise in
55
conditions
Dr. Stephen J. Forman
Hematology | Oncology
Referral may be required

City Of Hope Comprehensive Cancer Center-Duarte

1500 Duarte Rd, 
Duarte, CA 
 (38.0 miles away)
888-304-3959
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Stephen Forman is a Hematologist and an Oncologist practicing medicine in Duarte, California. Dr. Forman is highly rated in 55 conditions, according to our data. His clinical expertise encompasses Non-Hodgkin Lymphoma, Acute Myeloid Leukemia (AML), Graft Versus Host Disease (GvHD), Bone Marrow Transplant, and Bone Marrow Aspiration.

Expertise in
31
conditions
Dr. Arun S. Singh
Hematology | Oncology
Expertise in
31
conditions
Dr. Arun S. Singh
Hematology | Oncology
Referral may be required

Sandra Fallon M.D. Inc.

2020 Santa Monica Blvd Ste 580, 
Santa Monica, CA 
 (47.7 miles away)
310-829-5471
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Arun Singh is a Hematologist and an Oncologist practicing medicine in Santa Monica, California. Dr. Singh is highly rated in 31 conditions, according to our data. His clinical expertise encompasses Adult Soft Tissue Sarcoma, Liposarcoma, Ewing Sarcoma, Tissue Biopsy, and Bone Marrow Aspiration.

Frequently Asked Questions about Dr. Mohammad H. Fekrazad

How do I make an appointment with Dr. Mohammad H. Fekrazad?

You can book an appointment with Dr. Mohammad H. Fekrazad by calling their office at 833-574-2273. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.

Is Dr. Mohammad H. Fekrazad a top-rated expert for Breast Cancer?

MediFind is an objective health platform that identifies experts based on real-world data. Dr. Mohammad H. Fekrazad is classified as an Advanced expert for Breast Cancer, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

What conditions does Dr. Mohammad H. Fekrazad specialize in?

While Dr. Mohammad H. Fekrazad is a Hematology Oncology, they have specific expertise in Breast Cancer, Pleuropulmonary Blastoma, and Squamous Cell Lung Carcinoma. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Hematology Oncology.

Does Dr. Mohammad H. Fekrazad participate in research or clinical trials?

Yes. Dr. Mohammad H. Fekrazad has published 1 articles and abstracts on conditions like Breast Cancer. You can view a list of Dr. Mohammad H. Fekrazad's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Does Dr. Mohammad H. Fekrazad accept my insurance?

Dr. Mohammad H. Fekrazad accepts most major insurance plans, including Cigna and Humana. We recommend calling the office directly at 833-574-2273 to verify that your specific plan is currently accepted before your visit.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Fekrazad's expertise for a condition
ConditionClose
      View All 15 Advanced Conditions
      View All 46 Experienced Conditions
      Want to save this doctor for later?
      Sign Up
      Is this your doctor?
      Find A Second Opinion
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile